<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02842879</url>
  </required_header>
  <id_info>
    <org_study_id>SantaMariaPortugal</org_study_id>
    <nct_id>NCT02842879</nct_id>
  </id_info>
  <brief_title>Outpatient Foley Cervix Priming</brief_title>
  <official_title>Outpatient Versus Inpatient Cervix Priming With Foley Catheter</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hospital de Santa Maria, Portugal</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hospital de Santa Maria, Portugal</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim was to conduct a non-blinded prospective randomized study at a tertiary hospital.&#xD;
      Inclusion criteria: term pregnancy with a single fetus in cephalic presentation, Bishop score&#xD;
      &lt; 6, gestational age &gt; 41 weeks or medical indication for induction of labor.&#xD;
&#xD;
      Patients will be randomized to outpatient or inpatient cervix priming with Foley catheter.&#xD;
&#xD;
      The primary outcome will be to compare the variation of Bishop score (difference between&#xD;
      Bishop score before and after application of Foley catheter) between outpatient and inpatient&#xD;
      groups. Secondary comparisons include: mode of delivery, Foley catheter&#xD;
      application-to-delivery time, inpatient time, sequential use of prostaglandins, infection and&#xD;
      maternal pain.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>January 2014</start_date>
  <completion_date type="Actual">December 2015</completion_date>
  <primary_completion_date type="Actual">December 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>variation of bishop score (difference between bishop score before and after application of foley catheter)</measure>
    <time_frame>up to 24 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>mode of delivery</measure>
    <time_frame>up to 24 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>induction-to-delivery time</measure>
    <time_frame>up to 24 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>maternal pain evaluated by visual analog scale for pain</measure>
    <time_frame>up to 24 months</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">120</enrollment>
  <condition>Outpatient Mechanical Cervix Priming</condition>
  <arm_group>
    <arm_group_label>Outpatient Foley cervix priming</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients randomized to outpatient cervix priming will have the insertion of the catheter in the same conditions defined by the Department protocol for inpatient cervix priming. They will be discharged after a reassuring cardiotocogram following the introduction of the Foley catheter. When discharged, the patients will be instructed to apply manual traction to the catheter every 6 hours and they will be given a written document with all the information that should bring them back to hospital.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Inpatient Foley cervix priming</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>The introduction of a deflated catheter (Foley catheter nº 16F) through the outer cervix orifice is preceded by iodine disinfection of the cervix. The intracervical catheter is distended with 40mL of a saline solution. The end of the catheter is taped to the medial portion of the thigh and manual traction is applied to the catheter every 6 hours. If it is not spontaneously extruded it is removed after 24h. Cervix priming occurs in an inpatient setting.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Outpatient Foley cervix priming</intervention_name>
    <description>Outpatient setting for cervix priming with Foley catheter</description>
    <arm_group_label>Outpatient Foley cervix priming</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  women with a single fetus in cephalic presentation&#xD;
&#xD;
          -  Bishop score &lt; 6&#xD;
&#xD;
          -  Gestational age &gt; 41 weeks or medical indication for induction of labor submitted to&#xD;
             cervix priming with Foley catheter&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  women with a fetus in noncephalic presentation&#xD;
&#xD;
          -  an indication for elective cesarean delivery&#xD;
&#xD;
          -  spontaneous labor&#xD;
&#xD;
          -  hydramnios (amniotic fluid index ≥ 25)&#xD;
&#xD;
          -  nonreassuring cardiotocogram&#xD;
&#xD;
          -  multiple pregnancy&#xD;
&#xD;
          -  rupture of membranes&#xD;
&#xD;
          -  active vaginal bleeding&#xD;
&#xD;
          -  indication for prophylaxis of Streptococcus group B infection&#xD;
&#xD;
          -  HIV infection&#xD;
&#xD;
          -  cervical injury&#xD;
&#xD;
          -  previous cesarean section with recurrent indication&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>15 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Catarina Policiano, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hospital de Santa Maria, Centro Hospitalar Lisboa Norte</affiliation>
  </overall_official>
  <verification_date>July 2016</verification_date>
  <study_first_submitted>July 15, 2016</study_first_submitted>
  <study_first_submitted_qc>July 20, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 25, 2016</study_first_posted>
  <last_update_submitted>July 20, 2016</last_update_submitted>
  <last_update_submitted_qc>July 20, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 25, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Hospital de Santa Maria, Portugal</investigator_affiliation>
    <investigator_full_name>Catarina Policiano</investigator_full_name>
    <investigator_title>Dr. Catarina Policiano</investigator_title>
  </responsible_party>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

